Quidel Corp. (QDEL) PT Raised to $27 at Barclays; Reiterates Overweight
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/14/2026
- Wall Street ends higher as SpaceX's market debut dominates
- SpaceX prices historic IPO at $135/share in largest ever new listing
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- UBS cuts gold price forecasts on delayed Fed easing outlook
- Brent falls to lowest since March on expected peace deal
- NASDAQ adds five companies to NASDAQ-100 index in quarterly rebalance
- Super Micro Computer establishes $1.25 billion stock sale agreement
- Wall Street ends higher as SpaceX's market debut dominates
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- SpaceX Shares Indicated To Open At $155
Quidel Reports First Quarter 2017 Financial Results
April 24, 2017 4:10 PM EDTSAN DIEGO, CA -- (Marketwired) -- 04/24/17 -- Quidel Corporation (NASDAQ: QDEL), a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, announced today financial results for the first quarter ended March 31, 2017.
First Quarter 2017 Highlights:
Total revenue was $73.7 million as compared to $50.3 million in the first quarter of 2016.Total influenza revenue increased 112% from the first quarter of 2016 to $40.8 million. Total Molecular revenues increased 48%... More